All News

Further to the Company’s announcement of 2 April 2026, which contained the Resolutions to be voted on at the requestioned general meeting of the Company (the “Requisitioned General Meeting”) to be held at 10.00 a.m. on Wednesday 29 April 2026 at Copthorne Hotel Slough-Windsor, Cippenham Lane, Slough, Berkshire, SL1 2YE, Physiomics provides the following statement from Dr Jim Millen, Chairman of the Company, and republishes...

Further to the Company’s announcement of 16 March 2026, Physiomics announces the publication of a circular (the “Circular”) containing details of a requisitioned general meeting of the Company (the “Requisitioned General Meeting”). The Requisitioned General Meeting will be held at 10.00 a.m. on 29 April 2026 at Copthorne Hotel Slough-Windsor, Cippenham Ln, Slough SL1 2YE.   A summary of the Board’s responses to the Request and Amended...

TR-1: Standard form for notification of major holdings Please click here to read in full...

TR-1: Standard form for notification of major holdings Please click here to read in full...

TR-1: Standard form for notification of major holdings Please click here to read in full...

Unless otherwise defined herein, the capitalised terms used in this announcement have the same meaning as those used in the Company's announcements released on 10 March 2026.       Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, announces that the General Meeting previously scheduled to convene at 10:00 a.m. on Tuesday 7 April...

Unless otherwise defined herein, the capitalised terms used in this announcement have the same meaning as those used in the Company's announcements released on 17 March 2026.       Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions is pleased to announce, further to the announcements made on 17 March 2026, the completion of...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE...

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that it has completed a revised placing, conditional on admission to trading on AIM, of, in aggregate, £490,000.00 (gross) from the issue of 122,500,000 new ordinary shares (the “Placing Shares”) at an issue price of £0.004 per Placing...

The directors of Physiomics plc (AIM: PYC) announce that at 2114h on 13 March 2026 they received a request submitted pursuant to section 303 of the Companies Act 2006 (the "Act") requiring the Board to convene a general meeting of the Company's shareholders (the "GM Request"). The GM Request was accompanied by a shareholder statement submitted pursuant to section 314 of the Act.   The GM Request...